Non-Optical Methods for High Speed Protein Control
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DEF ADVANCED RESEARCH PROJECTS AGCY
Contract Value
Not provided
Codes & Classification
Solicitation Number
DARPA-SN-26-89
NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Classification Code
AC12
Additional Details
Documents2
The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), has issued a Special Notice (DARPA-SN-26-89) titled "Non-Optical Methods for High Speed Protein Control." This notice seeks to engage the research and development community in identifying and advancing innovative, post-competitive, and awardable solutions that address the critical need for a new class of rapidly switchable, non-optogenetic protein domains. The overarching goal is to enable real-time cellular control through non-optical mechanisms, thereby supplementing and enhancing current synthetic biology platforms.
The scope of this procurement centers on the development of robust and versatile molecular tools capable of facilitating massless information transfer across cell membranes. Unlike traditional optogenetic approaches, which rely on light to control protein function, this initiative specifically targets non-optical methods, broadening the potential for cellular manipulation in environments or applications where optical access is limited or impractical. The intended outcome is the creation of a new molecular toolkit that can be seamlessly integrated into existing synthetic biology workflows, ultimately expanding the capabilities of researchers and practitioners in the field.
Key requirements for this opportunity include the demonstration of innovative approaches to protein domain engineering that allow for rapid and reversible switching, high specificity, and compatibility with real-time cellular processes. Solutions must be non-optogenetic in nature and should emphasize versatility and robustness to ensure broad applicability across various biological systems. Expected deliverables include proof-of-concept demonstrations, detailed technical documentation, and evidence of integration potential with current synthetic biology platforms.
This notice is classified under NAICS code 541714, "Research and Development in Biotechnology (except Nanobiotechnology)," reflecting its focus on advanced biotechnological research. The Product Service Code (PSC) is AC12, further indicating its alignment with research and development activities in the life sciences. The contracting entity is the Defense Advanced Research Projects Agency (DARPA), a federal office within the Department of Defense, with Dr. Jeffrey Zaleski serving as the primary point of contact. Interested parties may direct inquiries to [email protected].
The procurement is being conducted as a Special Notice, with DARPA BTO actively utilizing the ERIS Marketplace to identify and evaluate potential solutions. Contractors should note that this is not a traditional solicitation but rather an opportunity for innovative entities to present post-competitive, awardable concepts that meet the outlined objectives. No set-aside requirements or special considerations are specified in the notice.
The notice remains active, with a response deadline of January 1, 2027. Contractors with expertise in protein engineering, synthetic biology, and molecular tool development are encouraged to review the full notice and associated attachments, available via the official SAM.gov opportunity listing (Opportunity ID: 834caaf2b61048afb84a252010027b34), to determine alignment with their capabilities and to participate in this forward-looking research initiative.